Navigation Links
At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
Date:4/15/2008

management, inherently involve numerous risks and uncertainties, known and unknown, many of which are beyond Neurochem Inc.'s control. Such risks include but are not limited to: the impact of general economic conditions, general conditions in the pharmaceutical and/or nutraceutical industry, changes in the regulatory environment in the jurisdictions in which the Neurochem group does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation, that actual results may vary once the final and quality-controlled verification of data and analyses has been completed, as well as other risks disclosed in public filings of Neurochem Inc. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. The reader should not place undue reliance, if any, on any forward-looking statements included in this news release. These statements speak only as of the date made and Neurochem Inc. is under no obligation and disavows any intention to update or revise such statements as a result of any event, circumstances or otherwise, unless required by applicable legislation or regulation. Please see the Annual Information Form of Neurochem Inc. for further risk factors that might affect the Neurochem group and its business

For further information: Lise Hebert, PhD, Vice President, Corporate Communications, (450) 680-4572, lhebert@neurochem.com


'/>"/>
SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Otter Tail Corporation Holds 2008 Annual Meeting: Shareholders Elect Directors; Board Declares Quarterly Dividend
2. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
3. Northwest Hospital & Medical Center Hosts Health & Wellness Pavilion At Second Annual King 5 Healthy Living Expo
4. European Society of Human Reproduction & Embryology 24th annual meeting
5. Media advisory - Neurochems Annual and Special Meeting of Shareholders April 15, 2008
6. Neurochem Annual and Special Meeting of shareholders
7. With annual deaths from malaria on the rise: Scientists ask where is all the money going?
8. China Medical Technologies to Announce 4QFY2007 Financial Results, Declare Annual Cash Dividend and Provide FY2008 Annual Targets on June 12, 2008
9. HealthMEDX Hosts Annual User Group Conference
10. Abaxis to Present at the SunTrust Robinson Humphreys 37th Annual Institutional Unconference
11. Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,alead...sandsoftwareandCalgaryScientificInc.,aleadingprovi...ebversionofAegis(TM)Breast4DAdvancedVisualizations...ulyzero-footprintWebclientbasedmedicalimagingoffer...ormallowsforzero-footprintaccess-requiringnosoftwa...
(Date:11/25/2009)...d.,Nov.25/PRNewswire-USNewswire/--AnarticlebyJanet...ationandResearch,titled"ADifficultBalance-PainMana...09issueofTheNewEnglandJournalofMedicine. ,, (Lo...DALOGO ) ,, Inthearticle,WoodcockdiscussesFDAef...forthosewhoneeditandmanagingtherisksposedbyvarious...
(Date:11/25/2009)...lEndorsements,Business,andPressJoinEfforttoEducate.../--Onceagain,theNationalBipolarFoundationandtheMed...r"Safe,tilStable"program,whichisnowbeingwidelyacce...er.Today,theNationalBipolarFoundationreceivedaproc...fromtheLt.GovernorofLouisianaMitchLandrieu.TheNati...
(Date:11/25/2009)...very that grew out of a collaboration between UCLA...hope to the nearly 10 million Americans who suffer...own as hardening of the arteries, peripheral arter...em in which narrowed arteries reduce blood flow to... for vascular disease, heart attack and stroke, an...
(Date:11/25/2009)...d to fight rheumatoid arthritis, could help newly ...NESDAY, Nov. 25 (HealthDay News) -- A drug commonl...oid arthritis now also shows some promise in helpi..., The drug, rituximab (Rituxan), helped patient...hough the disease had destroyed some of their panc...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... MedicareSupplementPlans.co...nce agencies specializing in Medicare supplement i... cap on Medicare services and provide seniors with...ns.com: Legislation designed to remove Medicare&rs...
..., , , SCHAUMBURG, Ill., April 24 World Veterina...elationship between veterinarians and livestock fa...and Livestock Farmers: a winning , partnershi...cer of the American Veterinary Medical Association...
...SAN DIEGO - Researchers from the Children,s Cancer...n Cancer Center have discovered a new drug combina...uroblastoma, a childhood cancer. The study was pre...or, vandetanib, with 13-cis-retinoic acid (CRA), a...
...ditional impairment charge anticipated in the four...orium Group, Inc. (Nasdaq: ENCO ), a full servi...RO) that provides design, development, and managem... 2009 it received a letter from Nasdaq stating tha...
...mpany will showcase technologies for brachytherapy...c(TM) radiotherapy, and stereotactic body radiothe...an Medical Systems (NYSE: VAR ) will showcase th...n Chicago from April 25-30. , , "Varian offers st...
...ey finds that psychological needs are going unmet,...People with heart failure, and those who care for ...cal needs, a new study finds. , "Heart failure pat...lth Sciences Center, who was to present the study ...
Other Medicine News:Health News:MedicareSupplementPlans.com Says News Legislation Could Affect Physical, Speech Therapy Benefits for Medicare Recipients 2Health News:AVMA Celebrates World Veterinary Day 2Health News:Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation 2Health News:Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing 2Health News:Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing 3Health News:Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing 4Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 2Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 3Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 4Health News:Reduce Suffering, Urge Heart Failure Patients and Caregivers 2Health News:Reduce Suffering, Urge Heart Failure Patients and Caregivers 3
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, UnitedStatesDentalDevicesMarketAnalysis....com/p0158733/United-States-Dental-Devices-Market-...tatesDentalDevicesMarketAnalysisandForecaststo2015...ceforin-depthinformationanddatarelatingtotheUSdent...
(Date:11/25/2009)...HAM,Mass.,Nov.25/PRNewswire/--AccordingtoMillenniu...hnologymarketintelligence,thenearly$3billionUSmark...owthoverthenextfiveyearsdespitetherecenteconomicsl...tfindsthatthismarketwillremainhighlydynamicoverthe...ddevicesinpreviouslyunderservedsegmentsofthetrauma...
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, IntranasalDrugDelivery-USMarketTrends&a...Intranasal-Drug-Delivery---US-Market-Trends--Analy...switnessinganexpansionoftherapeuticapplicationsfro...hedeliveryofsystemictherapeuticdrugs.Thefutureofth...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5U of M part of 24185 million funded team tasked to improve global response to emerging pandemics 60411 1U of M part of 24185 million funded team tasked to improve global response to emerging pandemics 60411 2U of M part of 24185 million funded team tasked to improve global response to emerging pandemics 60411 3ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 1ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 2ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 3GREENBioPharma Dec 2 3 2009 10591 1
...apentadol Efficacy and Tolerability for Acute Pain...ted that up to 30 percent of all people who have s...uch as nausea and vomiting. The use of opioid pain...isk factor for experiencing these side effects. Na... and can have an impact on a patient,s recovery. ,...
...l to be Held at 9:00 a.m. Eastern Time Today, May ...herapeutics Corporation (Nasdaq: UTHR ) announce...istration (FDA) has approved ADCIRCA(TM) (tadalafi...nded dose of 40 mg, as the first once-daily phosph...ent of pulmonary arterial hypertension (PAH). ADC...
Other Medicine Technology:New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4
CONCERT® Spine VR Bone Cement
...urgeon describes samples taken with,the new Comp...ns a,cleaner cut and larger sample for histopath...s optimized vacuum and cutting edge., Unique "O ...cuum,in the needle so that suction concentrates ...
CVC 9005 Hematocrit Calibration Verification Control (for use with the IRMA TRUpoint Blood Analysis System)
QC 233 CO-Oximeter Control
Medicine Products: